{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T09:53:13Z","timestamp":1774605193229,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>\n                    The implementation of pediatric protocols for the treatment of adolescents and young adults (AYA) has led to an improvement in the survival rate of patients with acute leukemia (AL). However, the incidence of complications is higher in this population than in children. The objective of this study is to compare the occurrence of infectious complications during periods of severe neutropenia in children, adolescents, and young adults. This retrospective single-center observational study compares the incidence of infections during severe neutropenia episodes and the management of these between 2 groups (children and AYA) over a 4-year period (2017 to 2021). A total of 54 patients and 243 severe neutropenia episodes were examined, and 63 infections were identified. The incidence of infection was significantly higher in the AYA population (40% vs. 23%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.02), but this difference was linked to a higher frequency of acute myeloid leukemia. However, AYA population presents more catheter-related infections (12% vs. 2%, aOR: 6.4, 95% CI: 1.7-25.1,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.01) and infections of the skin and soft tissues (14% vs. 4%, aOR: 3.9, 95% CI: 1.2-12.8,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.03) irrespective of the type of leukemia. In conclusion, this study reveals that AYA had more infectious complications than children, particularly more catheter, skin, and soft tissue infections.\n                  <\/jats:p>","DOI":"10.1097\/mph.0000000000003175","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:01:41Z","timestamp":1773327701000},"page":"128-132","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Infectious Complications in Children, Adolescents, and Young Adults Treated for Acute Leukemia and Lymphoblastic Lymphoma: A Single-Center Experience"],"prefix":"10.1097","volume":"48","author":[{"given":"Olivia","family":"Pineau","sequence":"first","affiliation":[{"name":"Pediatric Infectious Disease, Service Urgences Post-Urgences P\u00e9diatriques"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Mollevi","sequence":"additional","affiliation":[{"name":"Institute Desbrest of Epidemiology and Public Health, INSERM"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Dutron","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Disease, Service Urgences Post-Urgences P\u00e9diatriques"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Bret","sequence":"additional","affiliation":[{"name":"Biological Hematology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Jeziorski","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Disease, Service Urgences Post-Urgences P\u00e9diatriques"},{"name":"PCCEI, CeR\u00e9MAIA, CHU Montpellier"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Sirvent","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, Montpellier University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8793-4903","authenticated-orcid":false,"given":"Alexandre","family":"Theron","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, Montpellier University Hospital"},{"name":"IRMB, University of Montpellier, Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"R1-20260327","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/CEJ.0000000000000006","article-title":"Childhood cancer survival in France, 2000\u20132008","volume":"23","author":"Lacour","year":"2014","journal-title":"Eur J Cancer Prev"},{"key":"R2-20260327","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1200\/JCO.2003.02.053","article-title":"Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials","volume":"21","author":"Boissel","year":"2003","journal-title":"J Clin Oncol"},{"key":"R3-20260327","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","article-title":"Pediatric-inspired therapy in adults with Philadelphia chromosome\u2013negative acute lymphoblastic leukemia: the GRAALL-2003 study","volume":"27","author":"Huguet","year":"2009","journal-title":"J Clin Oncol"},{"key":"R4-20260327","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/jayao.2020.0017","article-title":"Cancer among adolescents and young adults between 2000 and 2016 in France: incidence and improved survival","volume":"10","author":"Raze","year":"2021","journal-title":"J Adolesc Young Adult Oncol"},{"key":"R5-20260327","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/bjh.12292","article-title":"The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment-related mortality and not an increased relapse rate\u2014a population-based analysis of 25 years of the Austrian ALL-BFM (Berlin-Frankfurt-M\u00fcnster) Study Group","volume":"161","author":"Pichler","year":"2013","journal-title":"Br J Haematol"},{"key":"R6-20260327","doi-asserted-by":"crossref","first-page":"e28939","DOI":"10.1002\/pbc.28939","article-title":"Adolescents and young adult acute myeloid leukemia outcomes at pediatric versus adult centers: a population-based study","volume":"68","author":"Gupta","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20260327","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1002\/cncr.28342","article-title":"Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent\/young adult and younger patients: a report from the Children\u2019s Oncology Group","volume":"119","author":"Canner","year":"2013","journal-title":"Cancer"},{"key":"R8-20260327","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1200\/JCO.2010.28.3473","article-title":"Clinical pharmacology in the adolescent oncology patient","volume":"28","author":"Veal","year":"2010","journal-title":"J Clin Oncol"},{"key":"R9-20260327","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","article-title":"Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R10-20260327","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) consensus group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R11-20260327","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1200\/JCO.22.02224","article-title":"Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update","volume":"41","author":"Lehrnbecher","year":"2023","journal-title":"J Clin Oncol"},{"key":"R12-20260327","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cmi.2019.10.006","article-title":"The correct blood volume for paediatric blood cultures: a conundrum?","volume":"26","author":"Huber","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R13-20260327","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/cncr.22189","article-title":"Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol","volume":"107","author":"Hallb\u00f6\u00f6k","year":"2006","journal-title":"Cancer"},{"key":"R14-20260327","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1200\/JCO.2015.61.5385","article-title":"Pediatric-like acute lymphoblastic leukemia therapy in adults with lymphoblastic lymphoma: the GRAALL-LYSA LL03 study","volume":"34","author":"Lepretre","year":"2016","journal-title":"J Clin Oncol"},{"key":"R15-20260327","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/leu.2017.265","article-title":"Results of NOPHO ALL2008 treatment for patients aged 1\u201345 years with acute lymphoblastic leukemia","volume":"32","author":"Toft","year":"2018","journal-title":"Leukemia"},{"key":"R16-20260327","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/INF.0000000000004493","article-title":"New insights into infections\u2019 risk of adolescents and young adults treated for acute lymphoblastic leukemia","volume":"43","author":"Trimbour","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"R17-20260327","first-page":"83","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"R18-20260327","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1182\/blood-2007-05-091942","article-title":"Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia","volume":"110","author":"Sung","year":"2007","journal-title":"Blood"},{"key":"R19-20260327","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/s41390-020-1086-0","article-title":"Optimized blood culture strategy to document febrile neutropenia","volume":"89","author":"Lamy","year":"2021","journal-title":"Pediatr Res"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T09:00:12Z","timestamp":1774602012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003175","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"2025-04-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}